Eli Lilly and Co. agreed to drop patent infringement charges against generics maker Glenmark Pharmaceuticals Inc. USA as long as Glenmark adheres to any future rulings regarding a generic version of Strattera, an Eli Lilly drug used to treat attention deficit hyperactivity disorder.
(Source: www.iplaw360.com)
No comments:
Post a Comment